The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer-Reference-Cited by-同舟云学术

The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer

Published:2015-02 Issue:2 Volume:87 Page:169-175
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Arrieta Oscar,Cardona Andrés Felipe,Corrales Luis,Campos-Parra Alma Delia,Sánchez-Reyes Roberto,Amieva-Rivera Eduardo,Rodríguez July,Vargas Carlos,Carranza Hernán,Otero Jorge,Karachaliou Nikki,Astudillo Horacio,Rosell Rafael

Funder

Boehringer Ingelheim

Roche

Foundation for Clinical and Translational Research of Cancer

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference35 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Lung cancer in the Americas;Pan America Health Organization (PAHO),2013

3. Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure;Arrieta;J Thorac Oncol,2012